Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Urologic oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.urolonc.2013.07.006PMID 24140245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.

  2014cited by this paper
• Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.

  2013cited by this paper
• Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal Cancer

  2013cited by this paper
• Type 2 diabetes mellitus, insulin‐use and risk of bladder cancer in a large cohort study

  2013cited by this paper
• 1427 IMPACT OF STATIN USE ON ONCOLOGICAL OUTCOMES OF PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER TREATED WITH RADICAL CYSTECTOMY

  2013cited by this paper
• Effect of diabetes on endometrial cancer recurrence and survival.

  2013cited by this paper
• Re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16.

  2013cited by this paper
• Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies

  2013cited by this paper
• Diabetes worsens the surgical outcomes in cirrhotic patients with hepatocellular carcinoma.

  2012cited by this paper
• Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer

  2012cited by this paper
• Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma.

  2012cited by this paper
• Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.

  2012cited by this paper
• Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

  2012cited by this paper
• Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer.

  2012cited by this paper
• The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus

  2012cited by this paper
• Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

  2011cited by this paper
• Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU Guidelines. Eur Urol 2011;59:1009-18.

  2011cited by this paper
• Pioglitazone and bladder cancer.

  2011cited by this paper
• High dose human insulin and insulin glargine promote T24 bladder cancer cell proliferation via PI3K-independent activation of Akt.

  2011cited by this paper
• Diabetes and risk of bladder cancer

  2011cited by this paper
• Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

  2011cited by this paper
• Impact of diabetes mellitus on recurrence and progression in patients with non‐muscle invasive bladder carcinoma: A retrospective cohort study

  2011cited by this paper
• International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

  2010cited by this paper
• Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

  2010cited by this paper
• Does pre-existing diabetes affect prostate cancer prognosis? A systematic review

  2010cited by this paper
• Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer

  2010cited by this paper
• Metformin: taking away the candy for cancer?

  2010cited by this paper
• The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.

  2010cited by this paper
• Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.

  2009cited by this paper
• Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes

  2009cited by this paper
• Diabetes mellitus and risk of bladder cancer: a meta-analysis

  2006cited by this paper
• Metformin and reduced risk of cancer in diabetic patients

  2005cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

  1998cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

  1998cited by this paper

• Correlations between metformin and prognosis and adverse reactions in patients undergoing radical cystectomy followed by adjuvant GC chemotherapy for bladder cancer.

  2026cites this paper
• Metformin as an anti-cancer agent against bladder cancer acts via PD-L1 downregulation in an orthotopic mouse model

  2025cites this paper
• Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors

  2025cites this paper
• Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma

  2025cites this paper
• Metformin is Associated with Better Survival Rate of Localized Upper Tract Urothelial Carcinoma Patients with Type 2 Diabetes

  2023cites this paper
• Diabetes Is aRiskFactor for thePrognosis ofPatientswithBladder Cancer: A Meta-Analysis

  2022cites this paper
• Diabetes Is a Risk Factor for the Prognosis of Patients with Bladder Cancer: A Meta-Analysis

  2022cites this paper
• The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis

  2022cites this paper
• Preoperative Metabolic Syndrome and HDL-C Level Predict the Prognosis of Patients Following Radical Cystectomy: A Propensity Score Matching Study

  2022cites this paper
• Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis

  2022cites this paper
• Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies

  2022cites this paper
• Restoration of deficient DNA Repair Genes Mitigates Genome Instability and Increases Productivity of Chinese Hamster Ovary Cells

  2021cites this paper
• The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis

  2021cites this paper
• Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep- 2 to 5-Fluorouracil

  2020cites this paper
• Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study

  2020cites this paper
• Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.

  2020cites this paper
• Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?

  2019cites this paper
• Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions

  2019cites this paper
• Using human experience to identify drug repurposing opportunities: theory and practice

  2019cites this paper
• Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis.

  2018cites this paper
• Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients

  2018cites this paper
• The association between metabolic syndrome and bladder cancer susceptibility and prognosis: an updated comprehensive evidence synthesis of 95 observational studies involving 97,795,299 subjects

  2018influential citation
• Repurposing medicines for the adjuvant treatment of cancer: An evaluation of aspirin and metformin

  2018cites this paper
• Comparative analysis between radical cystectomy and trimodality therapy for clinical stage II bladder cancer – Experience from a tertiary referral center

  2017cites this paper
• UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis

  2017cites this paper
• Photochemical internalization (PCI) of bleomycin is equally effective in two dissimilar leiomyosarcoma xenografts in athymic mice.

  2017cites this paper
• Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature

  2017cites this paper
• Biomarkers From Systems Biology and “Omics” Studies

  2017cites this paper
• Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models

  2017cites this paper
• Drug Repurposing Review

  2017cites this paper
• Photochemical internalization in bladder cancer–development of an orthotopic in vivo model

  2017cites this paper
• Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

  2016cites this paper
• Diabetes Mellitus Type 2: A Driving Force for Urological Complications.

  2016cites this paper
• Association of smoking status with prognosis in bladder cancer: A meta-analysis

  2016cites this paper
• Potential role for metformin in urologic oncology

  2016cites this paper
• Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy

  2016cites this paper
• Histologic prognostic markers for renal cell neoplasia

  2016cites this paper
• Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways

  2015cites this paper
• The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

  2015influential citation
• Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients

  2015cites this paper
• Impact of stage and comorbidities on five-year survival after radical cystectomy in Poland: single centre experience

  2015cites this paper
• Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: A systematic review

  2015cites this paper
• Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.

  2015cites this paper
• Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy

  2015cites this paper
• Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies

  2015cites this paper
• The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis

  2014cites this paper
• Metformina adicionada a la quimioterapia contra la leucemia linfoblástica aguda

  2014cites this paper
• Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP

  2014cites this paper
• [Effect of metformin addition to an acute lymphoblastic leukemia chemotherapy treatment].

  2014cites this paper
• Indices antropométricos y bioquímicos en la valoración nutricional del neonato de peso muy bajo

  2014cites this paper